This protocol is judged by an institutional overview board, an independent group that assessments any scientific trials involving people. If a examine consists of a Schedule I drug, as soon as the board approves the protocol as ethical, the scientists have to submit an application for an investigational new drug (IND) range within the FDA.Prescript